Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
dose intensity
Description:
A measure of drug or chemotherapy dose delivered over time, used to characterize treatment exposure in oncology.
Related topics:
Breast Cancer Treatment Studies (11%),
Lymphoma Diagnosis and Treatment (7%)
OpenAlex ID:
keywords/dose-intensity
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010
·
Claire L. Tomlinson
, Rebecca Stowe
, et al.
·
Movement Disorders
·
4,395
Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
1993
·
Richard I. Fisher
, Ellen R. Gaynor
, et al.
·
New England Journal of Medicine
·
2,160
PDF
2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
2006
·
Thomas J. Smith
, James Khatcheressian
, et al.
·
Journal of Clinical Oncology
·
1,644
PDF
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
2000
·
S. Giacchetti
, B. Perpoint
, et al.
·
Journal of Clinical Oncology
·
1,414
The importance of dose intensity in chemotherapy of metastatic breast cancer.
1984
·
W Hryniuk
, H Bush
·
Journal of Clinical Oncology
·
879
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
2006
·
Hagop Kantarjian
, Yasuhiro Oki
, et al.
·
Blood
·
694
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
·
Boglarka Gyurkocza
, Brenda M. Sandmaier
·
Blood
·
657
Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
2001
·
C. N. Sternberg
, P. H.M. de Mulder
, et al.
·
Journal of Clinical Oncology
·
636
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
1994
·
William C. Wood
, Daniel R. Budman
, et al.
·
New England Journal of Medicine
·
587
PDF
Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer
1998
·
Daniel R. Budman
, Donald A. Berry
, et al.
·
JNCI Journal of the National Cancer Institute
·
582
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
1994
·
New England Journal of Medicine
·
555
PDF
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
1998
·
Stefano Pasquali
, J D Maqueo
, et al.
·
Journal of Clinical Oncology
·
554
Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification
2001
·
Andrew D. Seidman
, Monica N. Fornier
, et al.
·
Journal of Clinical Oncology
·
543
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
·
M.S. Aapro
, D.A. Cameron
, et al.
·
European Journal of Cancer
·
539
Pooled Analysis of Safety and Efficacy of Oxaliplatin Plus Fluorouracil/Leucovorin Administered Bimonthly in Elderly Patients With Colorectal Cancer
2006
·
Richard M. Goldberg
, Isabelle Tabah-Fisch
, et al.
·
Journal of Clinical Oncology
·
472
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
2011
·
Mario E. Lacouture
, Milan J. Anadkat
, et al.
·
Supportive Care in Cancer
·
459
PDF
Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.
1986
·
W Hryniuk
, M N Levine
·
Journal of Clinical Oncology
·
452
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial
1992
·
R Pettengell
, H Gurney
, et al.
·
Blood
·
436
PDF
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
2019
·
Richard Gray
, Rosie Bradley
, et al.
·
The Lancet
·
427
PDF
Prognostic Importance of 6-Mercaptopurine Dose Intensity in Acute Lymphoblastic Leukemia
1999
·
Mary V. Relling
, Michael L. Hancock
, et al.
·
Blood
·
393
Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.
1987
·
L Levin
, W M Hryniuk
·
Journal of Clinical Oncology
·
382
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
2008
·
Andrew DJ Pearson
, C Ross Pinkerton
, et al.
·
The Lancet Oncology
·
355
Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup
2007
·
Ian J. Lewis
, Marianne A. Nooij
, et al.
·
JNCI Journal of the National Cancer Institute
·
350
PDF
Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma
1992
·
Leo I. Gordon
, David Harrington
, et al.
·
New England Journal of Medicine
·
322
PDF
Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study
2000
·
Eric Van Cutsem
, Michael Findlay
, et al.
·
Journal of Clinical Oncology
·
320
Show more works
View as search
Works count:
3,224
Citation count:
80,500
Year
Topic
Type